MetaCap

Ascendis Pharma A/S (ASND) vs United Therapeutics (UTHR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Ascendis Pharma A/S (ASND) has outperformed United Therapeutics (UTHR) over the past year, gaining 20.1% versus a gain of 16.8%. Over five years, UTHR leads with a +186.5% price change compared with +75.7% for ASND. United Therapeutics is the larger company by market cap ($23.63 billion vs $16.58 billion), about 1.4 times the size.

On valuation, United Therapeutics trades at a lower forward P/E (17.4x vs 20.5x for Ascendis Pharma A/S).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASND+20.07%UTHR+16.83%
+34%+13%-8%
Nov 21, 20251 yearNov 20, 2026
ASND+69.83%UTHR+175.81%
+210%+72%-66%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASND versus UTHR key metrics
MetricASNDUTHR
Share price$252.73$554.73
Market cap$16.58B$23.63B
1-day change-1.26%-0.78%
YTD return+18.52%+13.85%
1-year return+20.07%+16.83%
5-year return+75.73%+186.47%
P/E ratio (TTM)16.6220.94
Forward P/E20.4717.44
EPS (TTM)$15.21$26.49
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$3.18B
Revenue growth (YoY)—+10.61%
Net income (latest FY)—$1.33B
Gross margin—87.92%
Operating margin—46.89%
Net margin—41.94%
52-week high$282.15$614.23
52-week low$188.08$455.63
Distance from 52-week high-10.43%-9.69%
Analyst consensusstrong_buybuy
Avg. price target upside+24.95%+23.87%
Average volume750.65K702.78K
Shares outstanding65.60M42.59M
Employees1,1891,400
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • United Therapeutics trades at a higher earnings multiple (20.9x vs 16.6x trailing P/E).

About Ascendis Pharma A/S

ASND stock →

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism.

Health Care · Biotechnology: Pharmaceutical Preparations · 1,189 employees

About United Therapeutics

UTHR stock →

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients.

Health Care · Biotechnology: Pharmaceutical Preparations · 1,400 employees

ASND vs UTHR FAQ

Which is bigger, Ascendis Pharma A/S or United Therapeutics?

United Therapeutics (UTHR) is larger, with a market capitalization of $23.63B compared with $16.58B for Ascendis Pharma A/S (ASND).

Which stock has performed better over the past year, ASND or UTHR?

ASND returned +20.07% over the past 12 months, compared with +16.83% for UTHR (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ASND or UTHR?

ASND has the lower trailing P/E at 16.6, versus 20.9 for UTHR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Ascendis Pharma A/S and United Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons